About us
Avexxin Oncology AS is established as a Norwegian subsidiary company to the Swedish biotechnology company Coegin Pharma AB as part of Coegin Pharma AB’s hub & spoke “portfolio” biotech model, with clear benefits to investors. Avexxin Oncology AS will develop the promising novel and proprietary cancer drug candidate AVX420 further, and will primarily be financed separately from Coegin Pharma AB.
Management and Board of Directors
An experienced team with a strong track record, broad Nordic outreach and key competences
John R. Zibert
Chief Executive Officer
- Extensive experience in drug discovery and development
- Chief Medical Officer at Coegin Pharma AB
- Former founder and CEO at the digital CRO Studies&Me, Chief Medical Officer at LEO Innovation Lab, Head of Medical Affairs EU+ LEO Pharma A/S
- Ph.D. in immunology, M.Sc. human biology/medicine, with academic focus within Dermatology, Oncology, Cancer Biology, and digital health solutions
- Vast experience in clinical study design and execution, dermatology, oncology, research and development, innovation processes and medical affairs
Berit Johansen
Chief Scientific Officer
- Professor Norwegian University of Science and Technology (NTNU), Ph.D. in Molecular Genetics
- Vast experience in molecular biology,
inflammation and cancer research - Inventor of AVX420 and other AVX-derivatives
- CSO Coegin Pharma AB
- World leading researcher in academia University of Trondheim, Harward Medical School, UC Sandiego and with experience from the pahramceutical industry Biogen Research Corporation, Cambridge, USA, and Unigen, Trondheim, Norway
Tore Duvold
Chairman of the Board
- Extensive experience in biotech/pharma industries
- CEO Coegin Pharma AB
- SVP and head of research, early development and patent at LEO Pharma
- CEO and co-founder of Aker Biopharma, CEO and Board Member of Coegin Pharma
- Ex CEO of Innovation Fund Denmark
- Associated partner at Copenhagen Institute for Futures Studies
Erlend P. Skagseth
Board Member
- Currently, Managing Partner, Sarsia Seed AS
- Former experience from Christian Mikkelsen Research, Forinnova, and Sarsia Innovation
- Vast experience in turnarounds, licensing and exits
- Board Member of Coegin Pharma AB
Thoas Fioretos
Board Member
- Leading expert in the field of leukemia
- Professor at the Department of Clinical Genetics at Lund University
- Co-founder & Board Member Cantargia AB
- Co-founder & Board Member Qlucore AB
- Vast experience in cancer research with a focus on leukemia
- Board Member of Coegin Pharma AB